Experimental Hematology
Volume 38, Issue 1 , Pages 38-45 , January 2010

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

  • Sabine Nagel

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • Technical University of Berlin, Berlin, Germany
    • ,
  • Petra Hirschmann

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Stephan Dirnhofer

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Ursula Günthert

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • ,
  • Alexandar Tzankov

      Affiliations

    • Institute of Pathology, Basel, Switzerland
    • Corresponding Author InformationOffprint requests to: Alexandar Tzankov, M.D., Institute of Pathology, Schönbeinstrasse 40, CH 4031 Basel, Switzerland

Received 24 August 2009 ,Revised 19 October 2009 ,Accepted 20 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(09)00401-9

doi: 10.1016/j.exphem.2009.10.010

Experimental Hematology
Volume 38, Issue 1 , Pages 38-45 , January 2010

Article Tools

* Image Usage & Resolution